United States Steel Corporation (NYSE:X) has released its third-quarter 2024 guidance, forecasting adjusted net earnings per diluted share between $0.44 and $0.48.
Vanda Pharmaceuticals (NASDAQ:VNDA) announced that the U.S. Food and Drug Administration (FDA) has declined to approve its drug, tradipitant, aimed at treating symptoms of stomach paralysis, also known as gastroparesis.
